Company: FVN
Filing Date: 2025-04-14
Form Type: DRS/A
Source: 0001829126-25-002616
Chunk: 50

Company: Future Vision II Acquisition Corp.
Filing Date: 2025-04-14
Form: DRS/A
Chunk 50
---
 VIWO’s business, restrict its access to foreign investment, and negatively affect the value of its securities.

Recently, the China Securities Regulatory Commission introduced new regulations (the “Trial Measures”) governing overseas listings for domestic companies. These regulations require VIWO to complete specific filing procedures with the CSRC. However, as of the date of this document, VIWO has initiated such filing procedures with CSRC but has not yet completed them, which could lead to regulatory penalties and hinder its ability to list on foreign exchanges. In addition, there can be no guarantee that these filings will ever be completed, in which case the Business Combination may not be consummated.

While new cybersecurity regulations have been implemented in China, VIWO has confirmed that, based on PRC legal counsel’s assessment, its operations and listing are not expected to be affected by these measures at this time. However, please refer to “Risk Factors - VIWO may be liable for improper use or appropriation of personal information provided directly or indirectly by its customers or end users”to understand a fuller scope of the associated risks.

In summary, investing in New VIWO carries inherent risks associated with the complexities and uncertainties of the Chinese regulatory environment. These risks could materially impact New VIWO’s business operations, financial performance, and ability to access international capital markets. For more information, please refer to “Risk Factors – Risk Factors Relating to Doing Business in China.”

Under the Holding Foreign Companies Accountable Act (HFCAA) and Accelerating Holding Foreign Companies Accountable Act (AHFCAA), New VIWO’s securities could be prohibited from trading on U.S. exchanges if the SEC determines that its auditor hasn’t been subject to PCAOB inspections for two consecutive years. VIWO’s auditor is, and following consummation of the Business Combination, New VIWO’s auditor will be, headquartered in the U.S. and subject to regular inspection by the PCAOB. This means New VIWO will not be affected by the PCAOB’s determinations that impact some foreign companies.

<div align='center'>22</div>

However, each year, the PCAOB will determine whether it can inspect and investigate completely audit firms in mainland China and Hong Kong, among other jurisdictions. If the PCAOB determines in the future that it no longer has full access to inspect and investigate completely accounting firms in mainland China and New VIWO uses an accounting firm headquartered in one of these jurisdictions to issue an audit report on its financial statements filed with the SEC, New VIWO would be identified as a Commission-Identified Issuer